Category: pharmacological
Aliases: Spravato
S-enantiomer of ketamine — ~4× NMDA receptor affinity vs racemate. Intranasal formulation FDA-approved for treatment-resistant depression in conjunction with oral antidepressant. Rapid (hours) antidepressant effect; REMS for dissociation + abuse risk.
IN: 8h